Physician profile
Gary J Rogal
NPI 1447250196
$1,288.48
in general payments reported to CMS, 2019-2025
17 companies · $24.72 in 2025
The $24.72 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $281 · 2020: $104 · 2021: $108 · 2022: $389 · 2023: $294 · 2024: $87.59 · 2025: $24.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $407.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $406.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $252.80 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $186.36 | 2021-2024 | |
| Amgen INC. | $132.17 | 2019-2023 | Repatha |
| Abbott Laboratories | $128.71 | 2023-2025 | Cardiomems |
| Irhythm Technologies, INC. | $112.98 | 2020-2024 | Zio Monitor, Zio Xt Patch |
| Novo Nordisk INC | $97.51 | 2022-2023 | Ozempic, Rybelsus |
| Amarin Pharma, INC. | $84.67 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $70.98 | 2022 | |
| Atricure, INC. | $52.50 | 2022 | |
| Davol INC. | $47.03 | 2019 | |
| Pfizer INC. | $42.91 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $14.47 | 2019 | |
| Merck Sharp & Dohme LLC | $14.39 | 2022 | |
| Eisai INC. | $13.08 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $13.05 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $12.50 | 2019 | |
| Welch Allyn | $12.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Rogal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.